GlassScriptPhysician profile
Nicole Palomar
NPI 1417204645
$1,114.05
in general payments reported to CMS, 2019-2025
19 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $37.03 · 2021: $108 · 2022: $126 · 2023: $224 · 2024: $119 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.45 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $158.62 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $139.02 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $136.44 | 2021-2025 | Fluent Fluid Management System, Novasure, Acessa Provu System |
| Exeltis, USA INC. | $97.16 | 2024-2025 | Slynd |
| Mayne Pharma Commercial LLC | $69.33 | 2022-2025 | |
| Myovant Sciences INC. | $58.05 | 2021-2022 | |
| Organon LLC | $48.28 | 2022-2024 | Nexplanon |
| Evofem Biosciences, INC. | $46.93 | 2022-2025 | Solosec, Phexx, Phexxi |
| Lupin INC. | $38.90 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.87 | 2025 | |
| Exact Sciences Corporation | $15.66 | 2023 | Cologuard Collection Kit |
| Vertical Pharmaceuticals, LLC | $15.00 | 2019 | |
| Pfizer INC. | $14.99 | 2021 | |
| Duchesnay USA Incorporated | $14.10 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $14.06 | 2019 | |
| Celularity INC. | $14.00 | 2019 | |
| Urovant Sciences INC | $13.97 | 2022 | |
| Medicem INC. | $13.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Palomar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.